Sitemap
- Patient Support
- Products
- Privacy Policy
- Terms & Conditions of Use
- Cookie Policy
- My Account
- Login
- Sitemap
- Campus MY Sanofi Terms of Use
- Campus MY Sanofi PDPN
- Search
- Error 404
- Registration
- Science
- Cutting Edge Science
- Cardiovascular
- General
- Hypertension
- 2022
- 2023
- Personalized Hypertension Management: Watch Prof. Konstantinos Tsioufis's expert video
- Effect of intensive blood pressure (BP) control treatment on long-term all-cause and cardiovascular (CV) mortality in patients with hypertension
- Comparison of American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension blood pressure/ hypertension guidelines
- 2024
- Effect of ARB-based therapy in hypertensive patients with hyperuricemia and microalbuminuria
- Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers in patients with hypertension
- Self-reported single adherence question scored on a visual analogue scale predicts cardiovascular outcomes and mortality
- 2022
- Acute Coronary Syndrome
- 2022
- 2023
- Exploring Dual Antiplatelet Therapy Approaches in Acute Coronary Syndrome
- Study Reveals Optimized Antiplatelet Therapy Approaches for Acute Coronary Syndrome Patients
- Safety and Efficacy of DAPT in Elderly Patients with CAD
- A real-world study: Ticagrelor vs Clopidogrel in Elderly ACS patients undergoing PCI
- Use of SAPT vs DAPT beyond 12 months in patients with AMI: Clinical impact on ischemic risk
- Prognostic implications of P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention
- 2024
- Charting the Course of Antiplatelet Therapy in Elderly ACS Patients
- Charting the Course of Antiplatelet Therapy in ACS Patients
- Evolving strategies in CAD Management
- Crossroads of Cardiovascular Care: Insights into PCI and AMI Treatment Strategies
- Optimizing Treatment Strategies in Acute Coronary Syndrome
- Enhancing Antiplatelet Therapy for Older Patients: Balancing Risks and Benefits
- De-Escalation Strategies, Gender Differences, and Monotherapy Efficacy
- Antiplatelet Therapy and Statin Strategies in ACS: A Deep Dive into Efficacy and Safety
- Advances in Antiplatelet Therapy: Improving Outcomes with Tailored Approaches
- Refining Dual Antiplatelet Therapy: Latest Evidence for Stroke and ACS
- 2025
- 2022
- Central Nervous System
- 2022
- 2023
- Identifying antipsychotics and/or mood stabilizers for maintenance phase in Bipolar Disorder
- Effect of immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure
- CINP Guidelines: Definition and treatment management for resistant bipolar disorder
- Identifying antipsychotics and/or mood stabilizers for maintenance phase in Bipolar Disorder
- World Bipolar Day 2023
- SANAD II trial proves valproate is more clinically effective than levetiracetam in idiopathic generalised epilepsy1
- International Epilepsy Day 2023
- Limiting suicidal risk in bipolar disorders: Suicide cannot be “treated” but can be “prevented”1
- Sudden unexpected death in epilepsy: The role of physiologic effects and clinical factors related to convulsive seizures
- 2022
- Immunology
- Neurology
- 2023
- High-risk TIA patients under treated with Clopidogrel-Aspirin in emergency setting
- Hear from the expert - Prof Pierre Amarenco on efficiently managing TIA and minor stroke to reduce risk of recurrent stroke
- Dual antiplatelet therapy for treatment of patients with High-Risk transient ischemic attack and Stroke by emergency medicine Physicians: A national survey
- A Caregiver perspective on Bipolar Disorder
- Long-term protection in Antithrombotic treatment after Ischaemic Stroke/ TIA
- Dual Antiplatelet therapy for secondary prevention in ischemic stroke –Trends in prescription patterns after pivotal trials and guideline updates
- 2025
- 2023
- Rare Disease
- Thrombosis
- Vaccines
- Cardiovascular
- Events
- Cutting Edge Science
